Finder makes money from featured partners, but editorial opinions are our own. Advertiser disclosure

How to buy Landos Biopharma Inc stock (Landos Biopharma Inc)

Buy Landos Biopharma Inc stock in 5 easy steps, view past price performance and learn what’s ahead for the company.

Landos Biopharma Inc is a biotechnology business based in the US. Landos Biopharma Inc shares (LABP) are listed on the NASDAQ and all prices are listed in US Dollars. Landos Biopharma Inc employs 19 staff and has a market cap (total outstanding shares value) of 0.00.

Our top picks for where to buy Landos Biopharma stock

Top pick for advanced traders

Go to site
Get up to $5,000 cash
  • Trade options, futures, options on futures, stocks, ETFs
  • $0 commission to close options
  • Pro-grade platform and risk analysis tools

Best for beginners

Go to site
Get up to $1,000 in stock
  • Trade stocks, options, ETFs, mutual funds, alternative asset funds
  • $0 commission on stocks, ETFs and options, with no options contract fees
  • No-cost financial planning and automated investing

Our pick for cash sweep

Go to site
Advanced charts and trading tools
  • Trade stocks, ETFs and equity options without commission and $0 option contract fees
  • Earn up to 8.1% APY on your uninvested cash
  • Get a 1.5% match in cash on transferred assets up to $300 or up to 15 free fractional shares worth between $2 and $2,000

How to buy Landos Biopharma Inc stock

  1. Choose a stock trading platform. Use our comparison table
  2. Open an account. Provide your personal information and sign up.
  3. Fund your account. Deposit funds into your account by linking your banking information or transfer funds from another trading account.
  4. Search for the stock name – LABP. Search for the stock by name or ticker symbol.
  5. Buy the stock. Place your order. It's that simple.

Buy Landos Biopharma Inc stock from these online trading platforms

Compare special offers, low fees and a wide range of investment options among top trading platforms.
1 - 4 of 4
Name Product Ratings Available asset types Stock trade fee Minimum deposit Cash sweep APY Signup bonus
Finder Score: 4.4 / 5: ★★★★★
Stocks, Options, ETFs, Cryptocurrency, Futures, Treasury Bills
Get $50-$5,000
Competitive, capped options commissions, with a reliable trading platform designed for serious traders.
SoFi Invest®
Finder Score: 4.2 / 5: ★★★★★
SoFi Invest®
Stocks, Options, Mutual funds, ETFs, Alternatives
Get up to $1,000 in stock
Commission-free stocks, ETFs and options, with no options per-contract fees. Plus, a no-cost robo-advisor and complimentary access to certified financial planners (CFPs).
Finder Score: 4.3 / 5: ★★★★★
Stocks, Options, ETFs
Up to 8.10%
Choose a 1.5% match or up to 15 free fractional shares
No commission stock, ETF and options trades, with $0 equity options contract fees, low margin rates and advanced trading tools.
Finder Score: 4.2 / 5: ★★★★★
Stocks, Bonds, Options, ETFs, Cryptocurrency, Alternatives, Treasury Bills, High-yield cash account
Get up to $10,000 and transfer fees covered
Build a diversified portfolio of stocks, bonds, options, ETFs, crypto and alternative assets, with a high-yield cash account and options contract rebates.

Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.

Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.

Landos Biopharma Inc stock price (NASDAQ: LABP)

Use our graph to track the performance of LABP stocks over time.

Landos Biopharma Inc shares at a glance

Information last updated 2024-07-07.
Latest market close$0.00
52-week range$3.15 - $22.94
50-day moving average $20.19
200-day moving average $8.35
Wall St. target price$12.71
PE ratio N/A
Dividend yield N/A (0%)
Earnings per share (TTM) $-4.00

Is it a good time to buy Landos Biopharma Inc stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Landos Biopharma Inc price performance over time

Historical closes compared with the close of $0 from 2024-06-11

1 week (2024-07-01) nan%
1 month (2024-06-11) 0
3 months (2024-04-12) -100.00%
6 months (2024-01-12) -100.00%
1 year (2023-07-12) -100.00%
2 years (2022-07-12) -100.00%
3 years (2021-07-12) 10.49
5 years (2019-07-08) N/A

Landos Biopharma Inc financials

Gross profit TTM $18 million
Return on assets TTM -39.38%
Return on equity TTM -70.67%
Profit margin 0%
Book value $7.43
Market Capitalization $71.7 million

TTM: trailing 12 months

Landos Biopharma Inc share dividends

We're not expecting Landos Biopharma Inc to pay a dividend over the next 12 months.

Have Landos Biopharma Inc's shares ever split?

Landos Biopharma Inc's shares were split on a 1:10 basis on 25 May 2023. So if you had owned 10 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Landos Biopharma Inc shares – just the quantity. However, indirectly, the new 900% higher share price could have impacted the market appetite for Landos Biopharma Inc shares which in turn could have impacted Landos Biopharma Inc's share price.

Landos Biopharma Inc share price volatility

Over the last 12 months, Landos Biopharma Inc's shares have ranged in value from as little as $3.145 up to $22.94. A popular way to gauge a stock's volatility is its "beta".

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Landos Biopharma Inc's is 0.143. This would suggest that Landos Biopharma Inc's shares are less volatile than average (for this exchange).

To put Landos Biopharma Inc's beta into context you can compare it against those of similar companies.

Landos Biopharma Inc overview

Landos Biopharma, Inc. , a clinical-stage biopharmaceutical company, discovers and develops oral therapeutics for patients with autoimmune diseases. Its lead product candidate is NX-13, an oral gut-selective Nucleotide Oligomerization Domain (NLRX1), a mitochondria-associated receptor associated with the modulation of inflammatory cytokines that is in Phase 2 clinical trial to treat ulcerative colitis (UC) and completed Phase 1 to treat Crohn's disease (CD). The company's preclinical candidates in development include LABP-73, an oral and small molecule NLRX1 pathway agonist for the treatment of asthma and eosinophilic disorders; LABP-66 is an oral and small molecule NLRX1 pathway agonist for the treatment of multiple sclerosis and neurodegenerative disorders; and LABP-69, an oral PLXDC2 agonist for the treatment of rheumatoid arthritis, UC, and CD. The company has a license and collaboration agreement with LianBio Respiratory Limited to develop, manufacture, and commercialize omilancor and NX-13. Landos Biopharma, Inc. was incorporated in 2017 and is headquartered in Blacksburg, Virginia.

Frequently asked questions

What percentage of Landos Biopharma Inc is owned by insiders or institutions?
Currently 9.888% of Landos Biopharma Inc shares are held by insiders and 52.041% by institutions.
How many people work for Landos Biopharma Inc?
Latest data suggests 19 work at Landos Biopharma Inc.
When does the fiscal year end for Landos Biopharma Inc?
Landos Biopharma Inc's fiscal year ends in December.
Where is Landos Biopharma Inc based?
Landos Biopharma Inc's address is: 1800 Kraft Drive, Blacksburg, VA, United States, 24060
What is Landos Biopharma Inc's ISIN number?
Landos Biopharma Inc's international securities identification number is: US5150691021

More guides on Finder

Ask a Question provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and Terms of Use.

Questions and responses on are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Go to site